Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1
Summary
- Eligibility
- for people ages 18-50 (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- PepGen Inc
- ID
- NCT06204809
- Phase
- Phase 1 Myotonic Dystrophy Research Study
- Study Type
- Interventional
- Participants
- Expecting 24 study participants
- Last Updated